Lazard Asset Management’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Sell |
72
-4,856
| -99% | -$67.4K | ﹤0.01% | 2249 |
|
|
2025
Q1 | $98K | Buy |
+4,928
| New | +$98K | ﹤0.01% | 1815 |
|
|
2023
Q1 | – | Sell |
-2,183
| Closed | -$51K | – | 2339 |
|
|
2022
Q4 | $51K | Sell |
2,183
-1,910
| -47% | -$44.6K | ﹤0.01% | 1798 |
|
|
2022
Q3 | $106K | Buy |
4,093
+821
| +25% | +$21.3K | ﹤0.01% | 1448 |
|
|
2022
Q2 | $71K | Buy |
3,272
+1,995
| +156% | +$43.3K | ﹤0.01% | 1652 |
|
|
2022
Q1 | $57K | Buy |
+1,277
| New | +$57K | ﹤0.01% | 1676 |
|